BLRX
BioLineRX
BLRX
BLRX
12 hedge funds and large institutions have $3.91M invested in BioLineRX in 2013 Q2 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
12
Holders Change
+12
Holders Change %
–
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$2.58M |
| 2 |
SM
2
Senvest Management
New York
|
$1.01M |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$200K |
| 4 |
4
Renaissance Technologies
New York
|
$48K |
| 5 |
5
Bank of New York Mellon
New York
|
$29K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $2.58M | 1,589,500 | +1,589,500 | New |
|
|
SM
2
Senvest Management
New York
| $1.01M | 624,673 | +624,673 | New |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $200K | 124,002 | +124,002 | New |
|
|
4
Renaissance Technologies
New York
| $48K | 29,855 | +29,855 | New |
|
|
5
Bank of New York Mellon
New York
| $29K | 17,800 | +17,800 | New |
|
|
CS
6
Credit Suisse
Zurich,
Switzerland
| $25K | 15,432 | +15,432 | New |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $19K | 12,000 | +12,000 | New |
|
8
Wells Fargo
San Francisco,
California
| $2K | 1,000 | +1,000 | New |
|
9
Citigroup
New York
| $1K | 573 | +573 | New |
|
10
Ameriprise
Minneapolis,
Minnesota
| $0 | 10 | +10 | New |
|
|
SSG
11
Summit Securities Group
New York
| $0 | 11 | +11 | New |
|
12
Creative Planning
Overland Park,
Kansas
| $0 | 140 | +140 | New |
|